24-hour intraocular pressures with brimonidine purite versus dorzolamide added to latanoprost in primary open-angle glaucoma subjects.

Objective: To evaluate the 24-hour efficacy of brimonidine purite versus dorzolamide, each added to latanoprost.

Design: Double-masked, 2-center, prospective, crossover comparison.

Participants: Primary open-angle glaucoma (POAG) subjects.

Latanoprost 0.005% versus bimatoprost 0.03% in primary open-angle glaucoma patients.

Objective: To evaluate latanoprost versus bimatoprost given each evening over the 24-hour diurnal curve.

Design: Double-masked, 2-center, crossover comparison.

Participants: Forty-two of 44 patients with primary open-angle glaucoma (POAG) completed the study.

A comparison of once-daily morning vs evening dosing of concomitant latanoprost/timolol.

Purpose: To evaluate morning vs evening once daily concomitant latanoprost 0.005%/timolol maleate 0.5% therapy in ocular hypertensive or primary open-angle glaucoma patients.